Welcome to LookChem.com Sign In|Join Free
  • or
Benzenemethanol, 4-bromo-a-1-propynyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

550358-39-9

Post Buying Request

550358-39-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

550358-39-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 550358-39-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,5,0,3,5 and 8 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 550358-39:
(8*5)+(7*5)+(6*0)+(5*3)+(4*5)+(3*8)+(2*3)+(1*9)=149
149 % 10 = 9
So 550358-39-9 is a valid CAS Registry Number.

550358-39-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(4-Bromophenyl)-2-butyn-1-ol

1.2 Other means of identification

Product number -
Other names 1-(4-Bromo-phenyl)-but-2-yn-1-ol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:550358-39-9 SDS

550358-39-9Relevant academic research and scientific papers

Rhodium-Catalyzed C?H Activation/Annulation Cascade of Aryl Oximes and Propargyl Alcohols to Isoquinoline N-Oxides

Li, Yuan,Fang, Feifei,Zhou, Jianhui,Li, Jiyuan,Wang, Run,Liu, Hong,Zhou, Yu

supporting information, p. 3305 - 3310 (2021/05/17)

A β-hydroxy elimination instead of common oxidization to carbonyl group in secondary propargyl alcohols was successfully developed to form 2-benzyl substituted isoquinoline N-oxides by a Rhodium-catalyzed C?H activation and annulation cascade, in which moderate to excellent yields (up to 92%) could be obtained under mild reaction conditions, along with good regioselectivity, broad generality and applicability. (Figure presented.).

Regioselective Rh-Catalyzed Hydroformylation of 1,1,3-Trisubstituted Allenes Using BisDiazaPhos Ligand

Eshon, Josephine,Landis, Clark R.,Schomaker, Jennifer M.

, p. 9270 - 9278 (2017/09/22)

The efficient hydroformylation of 1,1,3-trisubstituted allenes is accomplished with low loadings of a Rh catalyst supported by a BisDiazaPhos (BDP) ligand. The ligand identity is key to achieving high regioselectivity, while the mild reaction conditions m

Metal-Free CH-CH-Type Cross-Coupling of Arenes and Alkynes Directed by a Multifunctional Sulfoxide Group

Fernández-Salas, José A.,Eberhart, Andrew J.,Procter, David J.

supporting information, p. 790 - 793 (2016/02/05)

A metal-free CH-CH-type coupling of arenes and alkynes, mediated by a multifunctional sulfoxide directing group, exploits nonprefunctionalized coupling partners, proceeds under mild conditions, is operationally simple, and exhibits high functional group t

Gold-catalyzed isomerization of unactivated allenes into 1,3-dienes under ambient conditions

Ting, Chun-Ming,Hsu, Yi-Ling,Liu, Rai-Shung

supporting information; experimental part, p. 6577 - 6579 (2012/07/31)

We have developed a gold-catalyzed isomerization of unactivated allenes into 1,3-dienes with nitrosobenzene as an additive. This reaction proceeded almost exclusively at room temperature for highly substituted allenes. The utility of this reaction is manifested by the development of one-pot [4+2]-cycloaddition of allenes and reactive alkenes.

S1P RECEPTORS MODULATORS AND THEIR USE THEREOF

-

Page/Page column 77, (2010/04/30)

The invention relates to novel compounds that have S1P receptor modulating activity. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression, for example, autoimmune response. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression such as autoimmune response.

Diastereoselectivity in the [2,3]-sigmatropic rearrangement of substituted allylic N,N-dialkylamidosulfoxylates. X-ray molecular structure of [(1′) S*, (S)S*]-(2′E)-4-[[3′-(4″-bromophenyl)-1′-methyl- 2′-propenyl]sulfinyl]-morpholine

Baudin, Jean-Bernard,Bkouche-Waksman, Itka,Hareau, Georges,Julia, Sylvestre A.,Lorne, Robert,Pascard, Claudine

, p. 6655 - 6672 (2007/10/02)

By the reaction with three N,N-dialkylamidosulfenyl chlorides 2 bearing representative sizes for the R groups on the nitrogen atom, several substituted secondary E or Z allylic alcohols (1a-h) have been converted into the corresponding pairs of diastereoisomeric allylic sulfinamides (3+-3′a-v), whose ratios have been determined by 1H NMR spectroscopy. Five cases of entirely diastereoselective [2,3]-sigmatropic rearrangement have been observed. The stereochemistry of one pure diastereoisomer 3′m has been determined by single crystal X-Ray analysis. When treated with 4-morpholinesulfenyl chloride, cyclohex-2-en-1-ol is stereoselectively converted to one diastereoisomer of the sulfinamide 5b which, by unambiguous procedures, led to the sane p.tolylsulfoxide 5a already obtained by treatment of cyclohex-2-en-1-ol with toluene-p-sulfenyl chloride.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 550358-39-9